Chemistry:WAY-181187

From HandWiki
Short description: Chemical compound
WAY-181187
WAY-181,187.svg
Clinical data
ATC code
  • none
Identifiers
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC15H13ClN4O2S2
Molar mass380.87 g·mol−1
3D model (JSmol)

WAY-181187 is a high affinity and selective 5-HT6 receptor full agonist.[1][2] It induces robust increases in extracellular GABA levels in the frontal cortex, hippocampus, striatum, and amygdala of rats without affecting concentrations in the nucleus accumbens or thalamus, and has modest to no effects on norepinephrine, serotonin, dopamine, or glutamate levels in these areas.[1][3] WAY-181187 has demonstrated preclinical efficacy in rodent models of depression, anxiety, and notably obsessive-compulsive disorder,[1][4] though it has also been shown to impair cognition and memory.[3][5]

See also

References

  1. 1.0 1.1 1.2 "Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466". Neuropsychopharmacology 33 (6): 1323–35. May 2008. doi:10.1038/sj.npp.1301503. PMID 17625499. 
  2. "Discovery of N1-(6-chloroimidazo[2,1-b][1,3]thiazole-5-sulfonyl)tryptamine as a potent, selective, and orally active 5-HT(6) receptor agonist". Journal of Medicinal Chemistry 50 (23): 5535–8. November 2007. doi:10.1021/jm070521y. PMID 17948978. 
  3. 3.0 3.1 "Activation of the 5-HT(6) receptor attenuates long-term potentiation and facilitates GABAergic neurotransmission in rat hippocampus". Neuroscience 164 (2): 692–701. December 2009. doi:10.1016/j.neuroscience.2009.07.061. PMID 19660530. 
  4. "Antidepressant and anxiolytic effects of selective 5-HT(6) receptor agonists in rats". Psychopharmacology 213 (2–3): 499–507. March 2010. doi:10.1007/s00213-010-1798-7. PMID 20217056. 
  5. "Pro-cognitive effects of 5-HT6 receptor antagonists in the social recognition procedure in rats: implication of the frontal cortex". Psychopharmacology 196 (1): 93–104. January 2008. doi:10.1007/s00213-007-0934-5. PMID 17922111.